Vol 71, No 2 (2020)
Clinical vignette
Published online: 2020-02-25
Long-term remission of steroid-resistant Graves’ orbitopathy after administration of anti-thymocyte globulin
Abstract
Not required for Clinical Vignette.
Keywords: Graves’ orbitopathyanti-thymocyte globulindysthyroid optic neuropathy
References
- Bartalena L, Baldeschi L, Boboridis K, et al. European Group on Graves' Orbitopathy (EUGOGO). The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. Eur Thyroid J. 2016; 5(1): 9–26.
- Kahaly GJ, Shimony O, Gellman YN, et al. Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin. J Clin Endocrinol Metab. 2011; 96(2): 422–429.
- Zand MS, Vo T, Huggins J, et al. Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation. 2005; 79(11): 1507–1515.
- Gurkan S, Luan Y, Dhillon N, et al. Immune reconstitution following rabbit antithymocyte globulin. Am J Transplant. 2010; 10(9): 2132–2141.
- Lee Y, Butani L, Glaser N, et al. Resolution of Graves' disease after renal transplantation. Pediatr Transplant. 2016; 20(4): 590–593.
- Blandford AD, Zhang D, Chundury RV, et al. Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management. Expert Rev Ophthalmol. 2017; 12(2): 111–121.
